Health Care & Life Sciences » Biotechnology | Aratana Therapeutics Inc.

Aratana Therapeutics Inc.

Aratana Therapeutics Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
47.67 M
Public Float
39.61 M
Aratana Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.27
Market Cap
$252.86 M
Shares Outstanding
49 M
Public Float
46.65 M

Profile

Address
11400 Tomahawk Creek Parkway
Leawood Kansas 66211
United States
Employees -
Website http://www.aratana.com
Updated 07/08/2019
Aratana Therapeutics, Inc. operates as a development stage biopharmaceutical company, which focuses on the licensing, development and commercialization of innovative prescription medications for pets or pet therapeutics. It delivers prescription medicines that address significant medical needs for cats and dogs. The firm licenses proprietary, patent-protected compounds from human pharmaceutical and biotechnology companies.

Financials

View All
Created with Highcharts 5.0.14Aratana Therapeutics Inc.Net Income. Fiscal year is January-December. All values USD Thousands.4 2874 28738 81638 81684 05484 05433 57533 57547 51047 51014 72214 722201320142015201620172018020k40k60k80k100k
Created with Highcharts 5.0.14Aratana Therapeutics Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.12312376776767867838 55138 55125 57325 57335 41235 412201320142015201620172018010k20k30k40k50k

Wendy L. Yarno
Non-Executive Chairman
Steven St. Peter
President, Chief Executive Officer & Director